Vimarsana
Biggest News Aggregation in the World

Page 3 - Functional Class News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Functional Class. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Functional Class Today - Breaking & Trending Today

Liquidia Corporation Announces $100 Million in New - Vimarsana News

Liquidia Corporation Announces $100 Million in New

Agreed to $75.0 million sale of common stock to fund affiliated with Patient Square Capital in a private placementAdditional advance of $25.0 million from...

Liquidia Corporation Announces $100 Million in New Financings - Vimarsana News

Liquidia Corporation Announces $100 Million in New Financings

Agreed to $75.0 million sale of common stock to fund affiliated with Patient Square Capital in a private placementAdditional advance of $25.0 million from HealthCare Royalty under current financing...

Liquidia Corporation Announces $100 Million in New Financings - Liquidia (NASDAQ:LQDA) - Vimarsana News

Liquidia Corporation Announces $100 Million in New Financings - Liquidia (NASDAQ:LQDA)

Agreed to $75.0 million sale of common stock to fund affiliated with Patient Square Capital in a private placementAdditional advance of $25.0 million from HealthCare Royalty under current financing agreement

U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent) - Liquidia (NASDAQ:LQDA) - Vimarsana News

U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent) - Liquidia (NASDAQ:LQDA)

Liquidia will pursue final FDA approval for YUTREPIA™ (treprostinil) inhalationLiquidia will immediately request that District Court set aside injunction tied to ‘793 patent MORRISVILLE, N.C., Dec. 20, 2023

U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent) -December 20, 2023 at 04:57 pm EST - Vimarsana News

U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent) -December 20, 2023 at 04:57 pm EST

Liquidia will pursue final FDA approval for YUTREPIA™ inhalationLiquidia will immediately request that District Court set aside injunction tied to ‘793 patent MORRISVILLE, N.C., Dec. 20, 2023 ...